Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-01

Clinical Trial Update: Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCC [NA]

View source ↗

Summary

The completed trial assessed whether sequential transarterial chemoembolization followed by portal vein embolization improves the resectability of hepatitis B–r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Portal vein embolization (PVE) (PVE)
  • Transarterial chemoembolization (TACE)

Snippet

Sponsor: Eastern Hepatobiliary Surgery Hospital | Conditions: Hepatocellular Carcinoma | NA | Status: COMPLETED